Abbott LaboratoriesABT -0.04%80 Net Margin % is 9.65% as of Mar. 2026, which is 29% below its 10-year median of 13.63. GuruFocus rates ABT with a GF Score™ of 80/100 and a GF Value™ of $129.49 (Significantly Undervalued). Among 817 Medical Devices & Instruments companies, Abbott Laboratories ranks better than 81.03% on this metric.
The historical rank and industry rank for Abbott Laboratories's Net Margin % or its related term are showing as below:
ABT'
s Net Margin % Range Over the Past 10 Years
Min: 1.74 Med: 13.63 Max: 31.95
Current: 13.91
ABT's Net Margin % is ranked better than 81.03% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs ABT: 13.91
Abbott Laboratories (NYSE:ABT) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Abbott Laboratories Net Margin % Related Terms
Abbott Laboratories Net Margin % Historical Data
* Premium members only.
The historical data trend for Abbott Laboratories's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Abbott Laboratories's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Net Margin % distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (ABT) has a Net Margin % of 9.65% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Abbott Laboratories and its competitors. This is 29% below median its historical median of 13.63. Over the past decade, Abbott Laboratories' Net Margin % has ranged from 1.74 to 31.95. According to the industry distribution chart, Abbott Laboratories ranks #155 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 19%.
Is Abbott Laboratories' Net Margin % too high?
Abbott Laboratories' current Net Margin % of 9.65% is 29% below median its 10-year median of 13.63. Over the past 10 years, this metric has ranged from a low of 1.74 to a high of 31.95. The Medical Devices & Instruments industry median Net Margin % is 2.07. Abbott Laboratories' value of 9.65% is 366.2% above this industry median. Based on the distribution chart, Abbott Laboratories ranks #155 out of 817 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Abbott Laboratories has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Net Margin % compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #155 out of 817 companies for Net Margin %. This places Abbott Laboratories in the top 19% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.07. Abbott Laboratories' value of 9.65% is 366.2% above this benchmark. Historically, Abbott Laboratories' own Net Margin % has ranged from 1.74 to 31.95 over the past decade. While the company's 10-year median is 13.63 vs. the industry median of 2.07, Abbott Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories's current Net Margin % of 9.65% is 366.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Abbott Laboratories and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current Net Margin % is 9.65%, which is 29% below median its own 10-year median of 13.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (ABT) is currently considered Significantly Undervalued. The stock's GF Value™ is $129.49, compared to a current price of $90.49 — trading 30.1% below its estimated fair value. The current Net Margin % is 9.65%, which is 29% below median its 10-year median of 13.63 and 366.2% above the Medical Devices & Instruments industry median of 2.07. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Abbott Laboratories (ABT), the current Net Margin % is 9.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of $90.49 is trading 30.1% below its estimated GF Value™ of $129.49.
GuruFocus considers Abbott Laboratories to be Significantly Undervalued.
Key valuation signals for ABT:
Net Margin %: 9.65% (29% below median its 10-year median of 13.63)
GF Value™: $129.49 vs. price of $90.49 (30.1% below fair value)
Industry Position: 366.2% above the Medical Devices & Instruments median (#155 of 817)
No single metric tells the full story. See the ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score
Get the complete analysis for ABT
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ABT has been successfully added to your 
